BioStock interviews Mia Lundblad, CEO at Arcede Pharma about COPD and the company’s development.
Arcede Pharma (publ) primarily develops drug candidates with the goal of launching drugs to treat chronic obstructive pulmonary disease (COPD) and severe asthma.
Arcede Pharma AB
Medicon Village, Scheeletorget 1, Lund, Sweden
Medicon Village SE-223 81 Lund, Sweden